Tag: chikungunya
Valneva: the chikungunya vaccine recommended in the United States
(AOF) – Valneva today announced that the Advisory Committee on Immunization (Acip) of the United States Centers for Disease Control and Prevention (CDC) recommends the use of its single-shot chikungunya…
Valneva expects an increase in sales in 2024 thanks to the chikungunya vaccine – 02/15/2024 at 11:51
(AFP/JUSTIN TALLIS) The Franco-Austrian pharmaceutical group Valneva is counting on an increase in its sales for 2024, notably with the marketing of its vaccine against chikungunya, Ixchiq, approved in the…
The Valneva laboratory is trying to relaunch itself with its vaccine against chikungunya
Thomas Lingelbach, CEO of Valneva, in Livingston, Scotland, March 28, 2022. ANDY BUCHANAN / AFP At the headquarters of the Franco-Austrian pharmaceutical laboratory Valneva, in Saint-Herblain (Loire-Atlantique), near Nantes, a…
Valneva: US FDA approves chikungunya vaccine for adults – 10/11/2023 at 08:17
valneva laboratory 1 (photo credit: Valneva Group / ) Valneva announced Friday that the U.S. Food and Drug Administration (FDA) has approved its single-dose chikungunya vaccine for people ages 18…
Valneva jumps after FDA approval of its chikungunya vaccine – 10/11/2023 at 09:12
(Photo credits: Valneva Group – ) (AOF) – The biggest increase in the SBF 120 index, Valneva jumped 8.31% to 6.83 euros after announcing the FDA approval of its vaccine…
First chikungunya vaccine approved in the United States
The chikungunya virus is transmitted to humans by infected mosquitoes. Here, an “Aedes aegypti” mosquito, in Ezeiza (Argentina), April 12, 2023. AGUSTIN MARCARIAN / REUTERS The United States approved, Thursday,…
EU to expedite review of Valneva chikungunya vaccine
Published on Oct 25, 2023 at 7:01 p.m. PARIS (Agefi-Dow Jones)–The biotechnology company Valneva announced on Wednesday that it had submitted an authorization request for its chikungunya vaccine to European…
Valneva: will present its research on chikungunya – 10/11/2023 at 6:07 p.m.
(CercleFinance.com) – Valneva announces today that it will make presentations on chikungunya at various leading scientific conferences organized during the fourth quarter of 2023. During IDWeek, the annual meeting of…
Valneva: will present its research on chikungunya
(CercleFinance.com) – Valneva announces today that it will make presentations on chikungunya at various leading scientific conferences organized during the fourth quarter of 2023. During IDWeek, the annual meeting of…
Valneva: Health Canada deems the chikungunya vaccine dossier admissible – 08/29/2023 at 09:50
(AOF) – Valneva (+0.88% to 6.43 euros) announces today that the regulatory agency Health Canada has completed the admissibility review of the marketing authorization application for its vaccine candidate single-shot…
Valneva: positive data from the chikungunya vaccine trial – 08/28/2023 at 08:35
Immunogenicity data from this clinical trial should be available in November 2023. (photo credit: Valneva Group / ) (AOF) – Valneva SE, a vaccines company, today announced positive early Phase…
Valneva: positive data from chikungunya vaccine trial
(AOF) – Valneva SE, a vaccines company, today announced positive early Phase 3 safety data in adolescents for its single-dose chikungunya (CHIKV) vaccine candidate, VLA1553. Immunogenicity data from this clinical…